John Szilagyi (left) is a Principal Scientist at Bristol Myers Squibb (NJ, USA), working in nonclinical development and investigative toxicology, with a focus on the development of models to study ...
A new in-plate, zero-disruption design enables reproducible organoid culture, downstream processing, and high-resolution imaging in a single 3D cell culture plate MONMOUTH JUNCTION, N.J., Feb. 9, 2026 ...
Research and drug discovery are undergoing a transformation, driven by the rise of 3D cell culture models that better replicate human biology. Unlike traditional 2D cultures and animal models, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results